Vaspin and its relation to cancer (Review)
- Shubham Agarwal
- Shreya Desai
Affiliations: Division of Internal Medicine, Chicago Medical School at Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA
- Published online on: September 23, 2021 https://doi.org/10.3892/wasj.2021.129
Copyright: © Agarwal
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Adipose tissue releases signaling molecules and hormones which are known as adipokines. Adipose tissue also provides a medium for low‑grade inflammation which occurs from adipocyte hypertrophy with ensuing hypoxia and cell death. Cancers are known to arise in states of low‑grade inflammation. There have been attempts to understand the role of adipokines in cancer pathogenesis and to establish their use as diagnostic and prognostic tools, as well as treatment targets. The present review article aims to highlight the role of vaspin in various types of cancer. Vaspin is known to inhibit apoptosis via the phosphatidylinositol‑3‑kinase/protein kinase B pathway, which has also been implicated in the development of colorectal cancer. The inhibition of the apoptosis of cells with malignant potential promotes tumor formation. At the same time, vaspin exhibits anti‑inflammatory and insulin‑sensitizing properties, which possibly confer its tumor inhibitory effects observed in endometrial cancer. However, its role either as a tumor promoter or inhibitor in other types of cancer in which it has not yet been studied would be difficult to predict.